Profile data is unavailable for this security.
About the company
Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.
- Revenue in USD (TTM)4.66bn
- Net income in USD700.00m
- Incorporated2000
- Employees9.80k
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122-4616United StatesUSA
- Phone+1 (858) 202-4500
- Fax+1 (858) 202-4766
- Websitehttps://www.illumina.com
More ▼
Mergers & acquisitions
| Acquired company | ILMN:NSQ since announced | Transaction value |
|---|---|---|
| IDbyDNA Inc | -2.42% | -- |
Data delayed at least 15 minutes, as of Jun 28 2022 20:39 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cognex Corporation | 1.08bn | 277.37m | 7.90bn | 2.26k | 29.37 | 5.81 | 26.56 | 7.31 | 1.55 | 1.55 | 6.03 | 7.82 | 0.5623 | 3.05 | 7.52 | 478,723.10 | 14.43 | 15.17 | 15.90 | 16.40 | 72.05 | 74.27 | 25.67 | 28.48 | 2.75 | -- | 0.00 | 44.87 | 27.88 | 14.39 | 58.86 | 14.22 | 3.82 | 10.68 |
| Bruker Corporation | 2.46bn | 282.00m | 9.53bn | 7.77k | 34.51 | 9.37 | 25.51 | 3.88 | 1.85 | 1.85 | 16.13 | 6.81 | 0.7465 | 1.70 | 6.65 | 316,574.40 | 8.65 | 7.68 | 12.06 | 10.50 | 50.33 | 47.94 | 11.59 | 9.57 | 1.72 | 23.83 | 0.5395 | 12.96 | 21.66 | 8.46 | 75.60 | 12.53 | 19.92 | 0.00 |
| Bio-Rad Laboratories, Inc. | 2.90bn | -101.13m | 15.02bn | 7.90k | -- | 1.49 | 469.69 | 5.19 | -4.88 | -4.88 | 96.34 | 340.10 | 0.2046 | 2.07 | 6.64 | 366,558.30 | -0.7145 | 24.42 | -0.7477 | 26.36 | 56.80 | 55.45 | -3.49 | 83.24 | 4.16 | 0.6824 | 0.1052 | 0.00 | 14.81 | 7.16 | 11.55 | 177.08 | -3.10 | -- |
| PerkinElmer, Inc. | 5.02bn | 740.94m | 18.29bn | 16.70k | 23.39 | 2.54 | 15.92 | 3.64 | 6.20 | 6.20 | 41.75 | 56.97 | 0.4251 | 3.87 | 5.23 | 300,534.30 | 6.28 | 6.63 | 7.12 | 7.70 | 54.70 | 52.31 | 14.76 | 14.32 | 1.43 | 9.16 | 0.4038 | 6.55 | 33.95 | 19.09 | 29.55 | 34.32 | 25.80 | 0.00 |
| Waters Corporation | 2.87bn | 704.55m | 19.89bn | 7.80k | 28.86 | 53.17 | 23.74 | 6.94 | 11.44 | 11.44 | 46.56 | 6.21 | 0.9173 | 3.35 | 4.95 | 367,679.60 | 22.54 | 16.20 | 29.48 | 19.44 | 58.57 | 58.48 | 24.57 | 24.16 | 1.75 | 24.44 | 0.7939 | 0.00 | 17.78 | 5.15 | 32.84 | 5.85 | 12.12 | -- |
| Fortive Corp | 5.37bn | 650.40m | 19.97bn | 18.00k | 30.71 | 2.09 | 18.72 | 3.72 | 1.81 | 1.80 | 14.97 | 26.68 | 0.3517 | 4.48 | 6.11 | 298,444.40 | 4.37 | 5.23 | 5.24 | 6.41 | 57.47 | 55.00 | 12.43 | 15.08 | 0.7395 | 8.78 | 0.281 | 14.06 | 13.38 | -0.4635 | -58.09 | -4.77 | -14.60 | 14.87 |
| Avantor Inc | 7.55bn | 534.40m | 21.54bn | 13.50k | 37.36 | 5.82 | 22.93 | 2.85 | 0.8562 | 0.8562 | 12.13 | 7.14 | 0.6406 | 5.94 | 5.93 | 559,325.90 | 5.08 | -- | 5.74 | -- | 34.17 | 32.51 | 7.93 | 2.42 | 1.18 | 4.81 | 0.6115 | -- | 15.52 | 60.60 | 876.92 | -- | 30.02 | -- |
| Keysight Technologies Inc | 5.14bn | 1.02bn | 25.55bn | 14.50k | 25.68 | 6.76 | 20.34 | 4.97 | 5.53 | 5.53 | 27.79 | 21.01 | 0.6655 | 2.34 | 6.95 | 359,510.50 | 13.24 | 7.68 | 15.98 | 9.25 | 63.96 | 58.17 | 19.90 | 11.73 | 2.26 | 16.64 | 0.3217 | 0.00 | 17.06 | 11.11 | 42.58 | 21.69 | 13.84 | -- |
| Mettler-Toledo International Inc. | 3.81bn | 793.32m | 25.95bn | 15.60k | 33.60 | 306.87 | 28.67 | 6.81 | 34.06 | 34.06 | 163.62 | 3.73 | 1.19 | 4.15 | 6.39 | 244,316.10 | 24.85 | 21.43 | 35.61 | 30.07 | 58.23 | 58.00 | 20.81 | 18.72 | 0.794 | 22.86 | 0.9568 | 0.00 | 20.51 | 8.19 | 27.58 | 14.88 | -2.79 | -- |
| AMETEK, Inc. | 5.79bn | 1.04bn | 26.03bn | 18.50k | 25.17 | 3.75 | 19.29 | 4.50 | 4.48 | 4.48 | 24.85 | 30.02 | 0.5134 | 5.16 | 6.78 | 312,935.00 | 9.25 | 8.84 | 10.53 | 10.20 | 34.48 | 36.20 | 18.02 | 16.73 | 0.8841 | 16.90 | 0.2679 | 16.88 | 22.17 | 7.63 | 13.48 | 14.09 | 11.83 | 17.32 |
| Illumina, Inc. | 4.66bn | 700.00m | 30.38bn | 9.80k | 42.17 | 2.79 | 30.56 | 6.52 | 4.58 | 4.58 | 30.23 | 69.39 | 0.3875 | 3.50 | 8.12 | 475,102.00 | 5.83 | 10.93 | 6.58 | 12.96 | 68.81 | 68.81 | 15.03 | 23.16 | 1.54 | -- | 0.1377 | 0.00 | 39.73 | 13.54 | 16.16 | 10.49 | -5.15 | -- |
| Agilent Technologies Inc | 6.53bn | 1.26bn | 36.02bn | 17.40k | 29.08 | 7.04 | 22.58 | 5.52 | 4.15 | 4.15 | 21.45 | 17.13 | 0.626 | 3.48 | 5.65 | 383,941.20 | 12.11 | 10.05 | 14.62 | 11.99 | 53.98 | 53.95 | 19.35 | 17.37 | 1.49 | 19.01 | 0.3619 | 22.52 | 18.36 | 8.50 | 68.29 | 21.24 | 6.34 | 11.36 |
| Roper Technologies Inc | 5.93bn | 1.00bn | 42.23bn | 19.30k | 42.59 | 3.12 | 25.88 | 7.12 | 9.36 | 27.02 | 55.57 | 127.95 | 0.2395 | 9.38 | 6.16 | 307,165.80 | 4.04 | 5.66 | 4.59 | 6.41 | 67.67 | 65.48 | 16.87 | 20.41 | 1.22 | 7.19 | 0.3549 | 19.20 | 19.03 | 8.80 | 19.03 | 8.33 | 9.31 | 13.40 |
Data as of Jun 28 2022. Currency figures normalised to Illumina Inc's reporting currency: US Dollar USD
44.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 31 Mar 2022 | 20.91m | 13.31% |
| The Vanguard Group, Inc.as of 31 Mar 2022 | 11.81m | 7.52% |
| Edgewood Management LLCas of 31 Mar 2022 | 8.74m | 5.56% |
| BlackRock Fund Advisorsas of 31 Mar 2022 | 7.55m | 4.81% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 6.40m | 4.07% |
| Wellington Management Co. LLPas of 31 Mar 2022 | 3.74m | 2.38% |
| Loomis, Sayles & Co. LPas of 31 Mar 2022 | 3.54m | 2.25% |
| Polen Capital Management LLCas of 31 Mar 2022 | 2.63m | 1.68% |
| Geode Capital Management LLCas of 31 Mar 2022 | 2.63m | 1.67% |
| Walter Scott & Partners Ltd.as of 31 Mar 2022 | 2.39m | 1.52% |
More ▼
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
